Berge KE - Search Results

1

Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidification.

Tveten K, Holla ØL, Cameron J, Strøm TB, Berge KE, Laerdahl JK, Leren TP. Tveten K, et al. Among authors: berge ke. Hum Mol Genet. 2012 Mar 15;21(6):1402-9. doi: 10.1093/hmg/ddr578. Epub 2011 Dec 8. Hum Mol Genet. 2012. PMID: 22156580

2

Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA.

Holla Ø, Teie C, Berge KE, Leren TP. Holla Ø, et al. Among authors: berge ke. Clin Chim Acta. 2005 Jun;356(1-2):164-71. doi: 10.1016/j.cccn.2005.01.028. Epub 2005 Mar 16. Clin Chim Acta. 2005. PMID: 15936313

3

[Cardiac ion channel disorders--diagnosis and treatment].

Haugaa KH, Berge KE, Früh A, Anfinsen OG, Arnestad M, Hallerud M, Gjesdal K, Leren TP, Amlie JP. Haugaa KH, et al. Among authors: berge ke. Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2778-81. Tidsskr Nor Laegeforen. 2005. PMID: 16244679 Free article. Review. Norwegian.

4

[DNA-based diagnostics of long QT syndrome].

Berge KE, Haugaa KH, Anfinsen OG, Früh A, Hallerud M, Jonsrud C, Øyen N, Gjesdal K, Amlie JP, Leren TP. Berge KE, et al. Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2783-6. Tidsskr Nor Laegeforen. 2005. PMID: 16244680 Free article. Norwegian.

5

Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy.

Berge KE, Ose L, Leren TP. Berge KE, et al. Arterioscler Thromb Vasc Biol. 2006 May;26(5):1094-100. doi: 10.1161/01.ATV.0000204337.81286.1c. Epub 2006 Jan 19. Arterioscler Thromb Vasc Biol. 2006. PMID: 16424354

6

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors.

Cameron J, Holla ØL, Ranheim T, Kulseth MA, Berge KE, Leren TP. Cameron J, et al. Among authors: berge ke. Hum Mol Genet. 2006 May 1;15(9):1551-8. doi: 10.1093/hmg/ddl077. Epub 2006 Mar 28. Hum Mol Genet. 2006. PMID: 16571601

7

Model system for phenotypic characterization of sequence variations in the LDL receptor gene.

Ranheim T, Kulseth MA, Berge KE, Leren TP. Ranheim T, et al. Among authors: berge ke. Clin Chem. 2006 Aug;52(8):1469-79. doi: 10.1373/clinchem.2006.068627. Epub 2006 Jun 1. Clin Chem. 2006. PMID: 16740646

8

Low-density lipoprotein receptor activity in Epstein-Barr virus-transformed lymphocytes from heterozygotes for the D374Y mutation in the PCSK9 gene.

Holla ØL, Cameron J, Berge KE, Kulseth MA, Ranheim T, Leren TP. Holla ØL, et al. Among authors: berge ke. Scand J Clin Lab Invest. 2006;66(4):317-28. doi: 10.1080/00365510600672775. Scand J Clin Lab Invest. 2006. PMID: 16777760

9

Analysis of alternatively spliced isoforms of human LDL receptor mRNA.

Tveten K, Ranheim T, Berge KE, Leren TP, Kulseth MA. Tveten K, et al. Among authors: berge ke. Clin Chim Acta. 2006 Nov;373(1-2):151-7. doi: 10.1016/j.cca.2006.05.031. Epub 2006 May 26. Clin Chim Acta. 2006. PMID: 16828075

10

Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly.

Holla ØL, Cameron J, Berge KE, Ranheim T, Leren TP. Holla ØL, et al. Among authors: berge ke. BMC Cell Biol. 2007 Mar 1;8:9. doi: 10.1186/1471-2121-8-9. BMC Cell Biol. 2007. PMID: 17328821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters